Comparative assessment of the efficiency of three new bronchodilators (salbutamol, terbutaline, Th 1165 a) in the management of patients with chronic obstructive lung disease.
D000328:Adult; D000336:Aerosols; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use*; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D012118:Resorcinols / Q000627:therapeutic use; D013147:Spirometry; D013997:Time Factors; D014797:Vital Capacity
D000336:Aerosols; D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D010636:Phenols; D012118:Resorcinols; D009921:Metaproterenol